NIH-funded research R03 grant

Predicting early Alzheimer's disease using advanced data analysis techniques

Official title: Early Alzheimers Forecasting from Multimodal Data via Deep Transfer Learning, Evaluated on a Large-Scale Prospective Cohort Study

Funded at University of Massachusetts Amherst · NIH-10732306 · Data updated 2026-11-12

This study is looking for new ways to spot Alzheimer's disease early by using different types of information, like genetics and brain scans, to help create smart tools that can predict how the disease might progress, making it easier for everyone to get the right care sooner.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst
NIH-funded
Lab location1 site (Hadley, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$287,118
NIH project number1R03AG083708-01
Project IDNIH-10732306 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at risk for Alzheimer's disease, particularly those with a family history or genetic predisposition.

Less likely to help

Patients with advanced Alzheimer's disease or those who do not have any risk factors for the disease may not benefit from this research.

What this research studies

This research aims to develop innovative methods for the early detection of Alzheimer's disease by analyzing various types of data, including genetic information, brain MRIs, and cognitive assessments. By utilizing deep transfer learning techniques, the project seeks to create models that can accurately predict the progression of Alzheimer's disease without needing extensive expert input on MRI scans. The study will evaluate these models on a large, diverse group of participants to ensure the findings are applicable to the general population. This approach could significantly enhance the ability to identify Alzheimer's disease in its early stages, potentially leading to better management and treatment options.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate detection of Alzheimer's disease, allowing for timely interventions and improved patient outcomes.

How similar studies have gone: Previous research has shown promise in using multimodal data and machine learning techniques for predicting Alzheimer's disease, indicating that this approach could be effective.

Where this research is happening

  • University of Massachusetts Amherst
    Hadley, United States
    Active

Researchers

  • Principal investigator: Fiterau Brostean, Madalina — University of Massachusetts Amherst
  • Study coordinator: Fiterau Brostean, Madalina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.